|

Neurobehavioral Therapy For Epilepsy And Major Depressive Disorder

RECRUITINGN/ASponsored by The University of Texas Health Science Center, Houston
Actively Recruiting
PhaseN/A
SponsorThe University of Texas Health Science Center, Houston
Started2024-12-19
Est. completion2025-02-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations2 sites
View on ClinicalTrials.gov →

NCT06695767

Summary

The purpose of this study is to examine the feasibility and acceptability of an online group Neuro-behavioral Therapy (NBT) with text messaging intervention for Veterans with epilepsy and major depressive disorder (MDD).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* English speaking veterans
* has home internet access
* has access to and familiarity in using a computer or tablet at least weekly
* Asymptomatic patients with chronic conditions
* has access to a mobile device with Short Message Service (SMS) text and picture capability
* has an active clinical diagnosis of major depressive disorder based on the International Classification of Diseases, 10th version (ICD-10)
* has an ICD-10 diagnosis of epilepsy with at least one seizure documented within the last five years

Exclusion Criteria:

* pregnancy
* Veterans that have current suicidal ideation
* have active psychosis; and have an ICD-10 diagnosis of psychogenic non-epileptic seizures or conversion disorder.

Conditions3

DepressionEpilepsyMajor Depressive Disorder

Locations2 sites

Michael E. DeBakey VA Medical Center
Houston, Texas, 77030
Melissa Fadipe, MSN, APRN, FNP-C(713) 825-7237Melissa.F.Fadipe@uth.tmc.edu
The University of Texas health Science Center at Houston
Houston, Texas, 77030
Melissa Fadipe, MSN, APRN, FNP-C(713) 825-7237Melissa.F.Fadipe@uth.tmc.edu

Browse More Trials

Depression trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.